Pharmacologic treatment of sleep apnea
HAYES, Inc.
Record ID 32006000131
English
Authors' objectives:
The goal of pharmacologic therapy for sleep apnea syndrome is to restore airway competence, to reduce morbidity and excessive mortality by reversing underlying hypoxia, hypercapnia, and acidosis, and to improve the quality of life for the patient.
Authors' methods:
Review
Details
Project Status:
Completed
Year Published:
2005
URL for published report:
http://www.hayesinc.com/hayes/crd/?crd=3057
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Sleep Apnea Syndromes
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
HAYES, Inc.
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.